Mandate

Vinge advises Axcel in connection with the investment in Sanviva

June 03, 2026 M&A Corporate Commercial FDI

Vinge has advised the Nordic private equity firm Axcel in connection with the establishment of Sanviva, a new European medical device distribution network.

Sanviva brings together medical device distributors Apodan, PartnerMed, AllweCare and XboXLab, operating across the Nordics and Benelux with a portfolio covering product categories such as wound care, ostomy care and in vitro diagnostics. Sanviva currently employs around 60 people across Denmark, Sweden, Norway, Finland, Belgium and the Netherlands.

The investment in Sanviva was made through Axcel Elevate I, Axcel’s lower mid-market fund focused on technology, business services and healthcare.

Vinge’s team consisted of Christina Kokko, Egil Svensson, Ida Appelgren, Manon de Cooman and Lina Björkman (M&A), Christoffer Nordin (Corporate Commercial), Dagne Sabockis and Julia Rydin (FDI) and Filippa Bergkvist (Transaction Support Coordinator).

Read the client’s press release. 

Related

Vinge has advised Orexo in connection with its rights issue

Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026

Vinge advises Axcel and Accru Partners in connection with the acquisitions of R3 Revisionsbyrå AB, Adrevicor Halland AB, Trevi Revision AB and Adrevicor Stockholm AB

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of R3 Revisionsbyrå AB, Adrevicor Halland AB, Trevi Revision AB and Adrevicor Stockholm AB.
October 08, 2026

Vinge has advised Folksam Group in connection with two investments in infrastructure funds

Vinge has advised Folksam Group in connection with two investments totalling SEK 7.2 billion in infrastructure funds managed by Copenhagen Infrastructure Partners and Arjun Infrastructure Partners, respectively.
October 08, 2026